eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cone rod dystrophy |
| Comorbidity | C0271051|macular oedema |
| Sentences | 3 |
| PubMedID- 23782868 | Aim: to evaluate the therapeutic effect of continuous treatment with topical dorzolamide (a carbonic anhydrase inhibitor) for cystoid macular oedema (cme) associated with retinitis pigmentosa (rp). |
| PubMedID- 24688265 | Inhibition of carbonic anhydrase with acetazolamide has previously been shown to result in increased retinal pump activity [7], and has been used in this regard to treat cystoid macular oedema associated with retinitis pigmentosa [6], x-linked retinoschisis [8] and enhanced s-cone syndrome [9] with some success. |
| PubMedID- 23000646 | Resolution of macular oedema associated with retinitis pigmentosa after intravitreal use of autologous bm-derived hematopoietic stem cell transplantation. |
Page: 1